Mengmeng Zhao

Mengmeng Zhao

Auto-generated profile, based on publicly available information

Mengmeng Zhao

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
MZMengmeng Zhao
Mengmeng Zhao
GXGang Xue
Gang Xue
BHBingxi He
Bingxi He
JDJiajun Deng
Jiajun Deng
TWTingting Wang
Tingting Wang
CCChang Chen
Chang Chen
Diagnosing lung cancer from indeterminate pulmonary nodules (IPLs) remains challenging. In this multi-institutional study involving 2032 participants with IPLs, we integrate the clinical, radiomic with circulating cell-free DNA fragmentomic features in 5-methylcytosine (5mC)-enriched regions to establish a multiomics model (clinic-RadmC) for predicting the malignancy risk of IPLs. The clinic-RadmC yields an area-under-the-curve (AUC) of 0.923 on the external test set, outperforming the single-omics models, and models that only combine clinical features with radiomic, or fragmentomic features in 5mC-enriched regions (p < 0.050 for all). The superiority of the clinic-RadmC maintains well even after adjusting for clinic-radiological variables. Furthermore, the clinic-RadmC-guided strategy could reduce the unnecessary invasive procedures for benign IPLs by 10.9% ~ 35%, and avoid the delayed treatment for lung cancer by 3.1% ~ 38.8%. In summary, our study indicates that the clinic-RadmC provides a more effective and noninvasive tool for optimizing lung cancer diagnoses, thus facilitating the precision interventions.

27 October 2020 in Journal of Virology
Verified
Journal Article
Open access
PDF file
MZMengmeng Zhao
Mengmeng Zhao
Asuka NanboAsuka Nanbo
Asuka Nanbo
DBDavid Becnel
David Becnel
ZQZhiqiang Qin
Zhiqiang Qin
GMGil Morris
Gil Morris
ZLZhen Lin
Zhen Lin
Epstein-Barr virus (EBV) is a ubiquitous human pathogen and associated with various human diseases. EBV undergoes latency and lytic replication stages in its life cycle. The transition into the lytic replication stage, at which virus is produced, is mainly regulated by the viral gene product, Zta. Therefore, the regulation of Zta function becomes a central issue regarding viral biology and pathogenesis. Known modifications of Zta include phosphorylation and sumoylation. Here, we report the role of ubiquitination in regulating Zta function. We found that Zta is subjected to ubiquitination in both EBV-infected and EBV-negative cells. The ubiquitin modification targets 4 lysine residues on Zta, leading to both mono- and polyubiquitination of Zta. Ubiquitination of Zta affects the protein’s stability and likely contributes to the progression of viral lytic replication. The function and fate of Zta may be determined by the specific lysine residue being modified.

5 October 2022 in European Journal of Cancer
Verified
Journal Article
Closed access
YSYunlang She
Yunlang She
SLShenghui Li
Shenghui Li
JDJiajun Deng
Jiajun Deng
YRYijiu Ren
Yijiu Ren
MZMengmeng Zhao
Mengmeng Zhao
CCChang Chen
Chang Chen

18 February 2020 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
MZMengmeng Zhao
Mengmeng Zhao
JDJiajun Deng
Jiajun Deng
YSYunlang She
Yunlang She
CCChang Chen
Chang Chen